My Portfolio
+
LINK YOUR PORTFOLIO

Organon & Co OGN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:31 PM EDT
13.38quote price arrow down-0.02 (-0.15%)
Volume
37,185
Close
13.40quote price arrow up+0.02 (+0.15%)
Volume
2,529,238
52 week range
5.69 - 13.48
Loading...
  • Open13.36
  • Day High13.40
  • Day Low13.36
  • Prev Close13.38
  • 52 Week High13.48
  • 52 Week High Date05/20/26
  • 52 Week Low5.69
  • 52 Week Low Date03/30/26

Latest On Organon & Co

Key Stats

  • Market Cap3.519B
  • Shares Out262.60M
  • 10 Day Average Volume3.15M
  • Dividend0.08
  • Dividend Yield0.60%
  • Beta1.54

KEY STATS

  • Open13.36
  • Day High13.40
  • Day Low13.36
  • Prev Close13.38
  • 52 Week High13.48
  • 52 Week High Date05/20/26
  • 52 Week Low5.69
  • 52 Week Low Date03/30/26
  • Market Cap3.519B
  • Shares Out262.60M
  • 10 Day Average Volume3.15M
  • Dividend0.08
  • Dividend Yield0.60%
  • Beta1.54

RATIOS/PROFITABILITY

  • EPS (TTM)0.94
  • P/E (TTM)14.28
  • Fwd P/E (NTM)3.84
  • EBITDA (TTM)1.764B
  • ROE (TTM)34.05%
  • Revenue (TTM)6.163B
  • Gross Margin (TTM)52.82%
  • Net Margin (TTM)3.99%
  • Debt To Equity (MRQ)948.95%

EVENTS

  • Earnings Date08/03/2026(est)
  • Ex Div Date05/11/2026
  • Div Amount0.02
  • Split Date-
  • Split Factor-

Related Video

Lightning Round: Halliburton is very inexpensive, says Jim Cramer
VIDEO5:3905:39
Lightning Round: Halliburton is very inexpensive, says Jim Cramer

Profile

MORE
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon...
Carrie Cox
Executive Chairman of the Board
Joseph Morrissey
Chief Executive Officer
Matthew Walsh
Chief Financial Officer, Executive Vice President
Daniel Karp
Executive Vice President - Corporate Development
Juan Ferreira
Executive Vice President, Head of Research and Development and Chief Medical Officer
Address
30 Hudson Street, Fl 33
Jersey City, NJ
07302
United States